Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
83%(5 trials)

Phase Distribution

Ph phase_4
3
27%
Ph not_applicable
5
45%
Ph phase_3
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(6)
Terminated(3)
Other(2)

Detailed Status

Completed6
Withdrawn3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (27.3%)
Phase 43 (27.3%)
N/A5 (45.5%)

Trials by Status

completed655%
withdrawn327%
unknown218%

Recent Activity

0 active trials
Showing 5 of 11
withdrawnphase_4

Prophylactic Analgesia for Bladder Botox Injections

NCT06514430
withdrawnnot_applicable

Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

NCT02757417
unknownnot_applicable

Using Phenazopyridine for In-office Cystoscopy

NCT02715648
completedphase_3

Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria

NCT01657448
unknownphase_4

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

NCT03755089
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06514430Phase 4

Prophylactic Analgesia for Bladder Botox Injections

Withdrawn
NCT02757417Not Applicable

Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

Withdrawn
NCT02715648Not Applicable

Using Phenazopyridine for In-office Cystoscopy

Unknown
NCT01657448Phase 3

Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria

Completed
NCT03755089Phase 4

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

Unknown
NCT03302936Phase 4

Assessing Pyridium for Post-Sling Urinary Retention

Completed
NCT02476448Not Applicable

Evaluation of Ureteral Jets on Cystoscopy

Completed
NCT03065075Phase 3

Effect of Phenazopyridine on Prolapse Surgery Voiding Trials

Completed
NCT02806713Phase 3

The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)

Completed
NCT02703558Not Applicable

Evaluation of Fluorescein Use During Cystoscopy

Withdrawn
NCT02424149Not Applicable

Phenazopyridine for Confirmation of Ureteral Patency

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11